EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children

Amanda de O E Moreira iD, Lêda Maria S Azevedo Neta, Márcia Pietroluongo iD, Ana Paula Dos S Matos iD, Beatriz B Correa iD, Beatriz H Ortiz iD, André da S Guimarães iD, Marcio Nele iD, Carollyne M Santos, Ana Elizabeth C Fai iD, Maria Helena Gonçalves iD, Flávio M Shimizu iD und 7 weitere

Pharmaceutics · 17.05.2025 · 17 (5) · 658

DOI: 10.3390/pharmaceutics17050658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 17.05.2025. Verfasst von Amanda de O E Moreira und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Industrial Technology (LabTIF), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Bra…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCTI/FINEP, FAPERJ, CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Pediatric drug administration is hindered by difficulties in swallowing conventional medications and the unpalatable taste of many drugs. Among diseases highlighting the need for improved pediatric delivery, tuberculosis (TB) stands out. One form of the disease is latent TB infection (LTBI), which is concerning in children. Effective LTBI treatment is crucial for prevention, with isoniazid (INH) widely used for its proven efficacy and safety. This study aims to develop innovative 3D-printed chewable gels containing INH for LTBI treatment.

Methods

The gels were formulated using gelatin and carrageenan gum, sugar-free sweeteners, and flavoring. Two batches were prepared, and using 3D printing (3DP) with a semi-solid extrusion (SSE) module, chewable gels were produced. Rheological properties were measured to assess the feasibility of 3DP-SSE, evaluating the structural integrity and adequate fluidity of the formulation. The 3D-printed chewable gels were evaluated by visual, mass, and dimensional characteristics. In addition, the water activity, texture profile, INH and degradation product content, in vitro release, and taste-masking were investigated.

Results

The optimized formulation maintained suitable rheological properties for 3DP-SSE, demonstrating consistent weight, dimensions, and stability after the process. The texture achieved a balance between printing parameters and shape maintenance, and the INH presented an immediate-release profile (>85% within 30 min). The chewable gels showed an improvement in palatability compared to conventional INH tablets.

Conclusions

This innovative approach offers a promising solution for pediatric LTBI treatment, as it improves efficacy, medication acceptability, and on-demand access.

Schlagwörter

Stichwörter der Autor:innen

3D printingchewable gelsisoniazidpediatric medicinespharmaceutical manufacturingrheologysemi-solid extrusiontuberculosis

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Industrial Technology (LabTIF), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
  • Laboratory of Experimental Pharmacotechnics, Department of Galenic Innovation, Oswaldo Cruz Foundation (FIOCRUZ), Farmanguinhos, Rio de Janeiro 22775-903, Brazil.
  • Colloid Engineering Laboratory, Alberto Luiz Coimbra Institute of Graduate Studies and Research in Engineering (COPPE), Federal University of Rio de Janeiro, Rio de Janeiro 21941-598, Brazil.
  • Food and Nutrition Graduate Program, Federal University of Rio de Janeiro State, Rio de Janeiro 22290-250, Brazil.
  • Laboratory of Multidisciplinary Practices for Sustainability (LAMPS), Institute of Nutrition, Rio de Janeiro State University (UERJ), Rio de Janeiro 20550-170, Brazil.
  • Gleb Wataghin Institute of Physics, State University of Campinas, Campinas 13083-859, Brazil.

ORCID-Profile: Amanda de O E Moreira, Márcia Pietroluongo, Ana Paula Dos S Matos, Beatriz B Correa, Beatriz H Ortiz, André da S Guimarães, Marcio Nele, Ana Elizabeth C Fai, Maria Helena Gonçalves, Flávio M Shimizu, Monique S Dos Santos, André Luis de A Guimarães, Alessandra L Vicosa

Förderung

  • MCTI/FINEP
  • FAPERJ
  • CNPq
  • CAPES

Zitieren

APA

Moreira, A. O. E., Neta, L. M. S. A., Pietroluongo, M., Matos, A. P. D. S., Correa, B. B., Ortiz, B. H., Guimarães, A. D. S., Nele, M., Santos, C. M., Fai, A. E. C., Gonçalves, M. H., Shimizu, F. M., Dos Santos, M. S., Moure, R. B., Nascimento, D. D., Guimarães, A. L. A., Junior, S. C. D. S. G., Vicosa, A. L., & Cabral, L. M. (2025). Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children. Pharmaceutics, 17(5), 658. https://doi.org/10.3390/pharmaceutics17050658

Vancouver

Moreira AOE, Neta LMSA, Pietroluongo M, Matos APDS, Correa BB, Ortiz BH, et al. Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children. Pharmaceutics. 2025;17(5):658. doi:10.3390/pharmaceutics17050658

BibTeX
@article{Moreira2025,
  author = {Moreira, Amanda de O E and Neta, Lêda Maria S Azevedo and Pietroluongo, Márcia and Matos, Ana Paula Dos S and Correa, Beatriz B and Ortiz, Beatriz H and Guimarães, André da S and Nele, Marcio and Santos, Carollyne M and Fai, Ana Elizabeth C and Gonçalves, Maria Helena and Shimizu, Flávio M and Dos Santos, Monique S and Moure, Rosemberg B and Nascimento, Diogo D and Guimarães, André Luis de A and Junior, Saint Clair Dos S G and Vicosa, Alessandra L and Cabral, Lucio M},
  title = {Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {658},
  doi = {10.3390/pharmaceutics17050658}
}
Kostenlos starten →